Great to join @AlzResearchUK in Parliament recently for their #DementiaUnseen event, celebrating the voices of over 67,000 people who’ve called for those affected by dementia to have the right to an early and accurate diagnosis. 🧡🧠

Drug maker Novo Nordisk has announced that its weight-loss drug semaglutide doesn’t slow memory or thinking decline in people with early Alzheimer’s. This is disappointing news for those affected by the disease.

https://t.co/SVyKU7c2wq

I've written about my thoughts, tangentially to the inquiry, on covid post-mortems. About confident maths, lack of confidence, and whether we should experiment on kids (we should). If I ever write about covid again, assume it's a hostage situation. https://t.co/F25b0jlidP

Great to join @AlzResearchUK in Parliament recently for their #DementiaUnseen event, celebrating the voices of over 67,000 people who’ve called for those affected by dementia to have the right to an early and accurate diagnosis.

Today our Chief Executive Cath Stanley is Chairing @NeuroAlliance AGM. Fighting for a better future for people affected by neurological conditions. Standing Together for the 1 in 6

"If this campaign helps even one person avoid the pain, fear and confusion of a delayed diagnosis, then it’s made a difference.” Yesterday, presenter Anneka Rice helped us deliver our #DementiaUnseen petition straight to Downing Street, alongside our ambassador Scott Mitchell

You can still support our dementia diagnosis petition. Sign online to help us keep pushing for change: https://t.co/qv3RuOmdXT

67,000 voices – one message that couldn’t be ignored. Today we delivered your signatures straight to 10 Downing Street, urging the Government fix the crisis in dementia diagnosis. Thank you so much to everyone who supported our #DementiaUnseen campaign.

We're now at Downing Street, about to deliver our petition calling on the Government for an early and accurate dementia diagnosis.

We did it — together.🧡 67,000 voices delivered to the Government to make sure no one with dementia goes unseen.

Welcome to our AGM and Community Conference. We hope you have a lovely time, don't forget to tag us in any photos

🧠 We’re setting an ambitious goal: diagnose 92% of dementia patients within 18 weeks of referral by 2029 - up from less than 50% today. From blood tests to AI, research and innovation can transform dementia care, improving lives and easing pressure on the NHS.

Great to see the issue of dementia diagnosis being raised in the Lords. Thank you @MRitchieSD 👏

Half of Brits fear dementia more than any other health condition. That’s one of the striking findings from our latest Dementia Attitudes Monitor, launched today. Find out more: https://t.co/LwVXDFE4Rs

That’s a wrap for this year’s party conferences! We’ve made new connections, asked tough questions & had important conversations about the future of #dementia diagnosis, treatment and prevention. Stay tuned for our event insights - coming next week!

Published today, @AlzResearchUK’s Dementia Attitudes Monitor has revealed the devastating reality of dementia. Half of UK adults fear it more than any other health condition. Read the full report here:

We're in Manchester, wrapping up party conference season with the @Conservatives. We'll be spotlighting our #DementiaUnseen campaign, and championing the need for better prevention, diagnosis and treatment to every MP we talk to. Find out more from the team below. #CPC25

That’s a wrap for the @UKLabour conference! Our team has been holding the Government to account – meeting MPs, asking tough questions, and highlighting the UK life science sector's crucial role in tackling #dementia. Listen to the team’s highlights below.

Care Minister @SKinnock spoke to @AlzResearchUK about his experience of #dementia and what’s next for the #NHS.   Here from him here: